Paramedic syncope risk score study
Part of Brain & nervous system clinical trials.
This trial studies how well a risk score can be used by paramedics to assess people who faint (“syncope”) after calling 911. It may help emergency teams decide how urgently you need care after a fainting episode.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must call 911 and receive care from paramedics.
- Your episode must be sudden fainting (brief loss of consciousness) with full recovery on your own.
- You were unconscious for 5 minutes or less.
- There should be no confusion or mental changes compared with your usual self afterward.
- No seizure was seen, and the fainting should not be caused by a head injury to start with.
- You (or your caregiver) must be able to give accurate details, without major language, thinking/memory problems, or intoxication from alcohol or drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether remote heart monitoring after an ER visit for fainting (syncope) can help identify dangerous heart problems. You may be enrolled only if your fainting episode seems medium- to high-risk and you’re being sent home from the ER.
This trial helps emergency departments use a simple risk score to guide care for adults who faint. It looks at whether using these recommended steps improves how syncope (fainting) is assessed and managed in the ER.
This study looks at whether people who come to the hospital after a fainting spell can be safely watched for 24 hours inside the hospital, instead of being admitted for a longer stay. It may help doctors decide the best way to monitor low- and intermediate-risk fainting.
This study looks at people who have had repeated fainting spells and still don’t know the cause. It tests whether different types of heart monitoring (like tilt testing or an ECG/heart tracing) can better explain what’s triggering syncope and guide prevention.
This trial tests a “global” approach to assessing episodes of fainting or falling in people age 40 and older. It may help doctors find the right cause and safer next steps after an episode.
This study tests a new way to detect and warn about fainting in people with certain types of syncope (temporary loss of consciousness). It may help those who have already had a specific fainting evaluation called an ARS assessment.
Hear when a new Syncope trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.